Amino acid based enantiomerically pure 3-substituted benzofused heterocycles: A new class of antithrombotic agents

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 1, 2010, Pages 244-247

  Mishra, Jitendra Kumar ^a   Samanta, Krishnananda ^a   Jain, Manish ^a   Dikshit, Madhu ^a   Panda, Gautam ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Amino acids; Antithrombotic activity; Benzodiazepines; Benzothiazepines; Benzoxazepines; Benzoxazocine

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID; OXAZEPINE DERIVATIVE; OXAZOCINE DERIVATIVE;

ANTICOAGULATION; ARTICLE; DRUG SYNTHESIS; ENANTIOMER; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

AMINO ACIDS; BENZODIAZEPINES; FIBRINOLYTIC AGENTS; HETEROCYCLIC COMPOUNDS, 2-RING; OXAZEPINES; OXAZOCINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 72049122105     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.10.126     Document Type: Article

References (44)

1. Gent M., Blakely J.A., and Easton J.D. Lancet 1 (1989) 1215
2. Rapaport S.I., and Rao L.V. Arterioscler. Thromb. 12 (1992) 1111
3. Coller B.S. In: Fozzard H.A., Haber E., Jennings R.B., Katz A.M., and Morgan H.E. (Eds). The Heart and Cardiovascular System. 2nd ed. (1991), Raven Press, New York
4. Monteal M., Lafoz E., Olive A., del Rio L., and Vedia C. Thromb. Haemostasis 71 (1994) 7
5. Landefeld C.S., Rosenblatt M.W., and Goldman L. Am. J. Med. 87 (1989) 153
6. Tabibian N. Am. J. Gastroenterol. 84 (1989) 10
7. Reviews:. Nubbemeyer U. Top. Curr. Chem. 216 (2001) 125
8. Maier M. Angew. Chem., Int. Ed. 39 (2000) 2073
9. Evans P.A., and Holmes B. Tetrahedron 47 (1991) 9131
10. Lindström U.M., and Somfai P. Chem. Eur. J. 7 (2001) 94
11. Bieräugel H., Jansen T.P., Schoemaker H.E., Hiemstra H., and van Maarseveen J.H. Org. Lett. 4 (2002) 2673
12. Derrer S., Davies J.E., and Holmes A.B. J. Chem. Soc., Perkin Trans. 1 (2000) 2957
13. Nicolaou K.C., Vourloumis D., Winssinger N., and Baran P. Angew. Chem., Int. Ed. 39 (2000) 44
14. Evans B.E., Rittle K.E., Bock M.G., DiPardo R.M., Freidinger R.M., Whitter W.L., Lundell G.F., Veber D.F., Anderson P.S., Chang R.S.L., Lotti V.J., Cerino D.J., Chen T.B., Kling P.J., Kunkel K.A., Springer J.P., and Hirschfield J. J. Med. Chem. 31 (1988) 2235
15. Sternbach L.H. J. Med. Chem. 22 (1979) 1
16. Bock M.G., Dipardo R.M., Evans B.E., Rittle K.E., Whitter W.L., Veber D.F., Anderson P.S., and Preidinger R.M. J. Med. Chem. 32 (1989) 13
17. Romer D., Buscher H.H., Hill R.C., Maurer R., Petcher T.J., Zeugner H., Benson W., Finnner E., Milkowski W., and Thies P.W. Nature 298 (1982) 759
18. Komecki E., Ehrlich Y.H., and Lenox R.H. Science 226 (1984) 1454
19. Hsu M.-C., Schutt A.D., Hooly M., Slice L.W., SherTnan M.I., Richman D.D., Potash M.J., and Volsky D.J. Science 254 (1991) 1799
20. Pauwels R., Andries K., Desmyter J., Schols D., Kukla M.J., Breslin H.J., Raeymaeckers A., Van Gelder J., Woestenborghs R., Heykants J., Schellekens K., Janssen M.A.C., Clercq E.D., and Janssen P.A.J. Nature 343 (1990) 470
21. Liao Y., Venhuis B.J., Rodenhuis N., Timmerman W., Wikstrom H., Meire E., Bartoszyk G.D., Bottcher H., Seyfried C.A., and Sundell S. J. Med. Chem. 42 (1999) 2235
22. Toshiyuki, H.; Tokuhiro, I., Hisao, Y. G. O. 2,014,223, 1969; Chem. Abstr. 1970, 73, 12069.
23. Standridge, R. T. U.S. 4,125,538, 1978; Chem. Abstr. 1979, 90, 72246r.
24. James G.L., Goldstein J.L., Brown M.S., Rawson T.E., Somers T.C., McDowell R.S., Crowley C.W., Lucas B.K., Levinson A.D., and Marsters Jr. J.C. Science 260 (1993) 1937
25. Díaz-Gavilán M., Rodríguez-Serrano F., Gómez-Vidal J.A., Marchal J.A., Aránega A., Gallo M.A., Espinosa A., and Campos J.M. Tetrahedron 60 (2004) 11547
26. Milligan G. Trends Pharmacol. Sci. 14 (1993) 413
27. Amblard M., Daffix I., Bedos P., Berge G., Pruneau D., Paquet J.-L., Luccarini J.-M., Belichard P., Dodey P., and Martinez J. J. Med. Chem. 42 (1999) 4185
28. Ron D., and Kazanietz M.G. FEBS J. 16 (1999) 1358
29. Kazanietz M.G., Caloca M.J., Fujii T., Eroles P., Garcia-Bermejo M.L., Reilly M., and Wang H. Biochem. Pharmacol. 60 (2000) 1417
30. In: Budavari S. (Ed). The Merck Index. 12th ed. (1996), Merck, Rahway, NJ 1105 and references cited therein
31. Klohs M.W., Draper M.S., Petracek F.J., Ginzel K.H., and Ré O.N. Arzneim.-Forsch. (Drug Res.) 22 (1972) 132
32. Mishra J.K., Garg P., Dohare P., Kumar A., Siddiqi M.I., and Ray M. Bioorg. Med. Chem. Lett. 17 (2007) 1326
33. Mishra J.K., and Panda G. J. Comb. Chem. (2007) 321
34. Shagufta, and Panda G. Org. Biomal. Chem. 5 (2007) 360
35. Mishra J.K., and Panda G. Synthesis (2005) 1881
36. Mishra J.K., Rao J.S., Sastry G.N., and Panda G. Tetrahedron Lett. 47 (2006) 3357
37. Srivastava A.K., and Panda G. Chem. A Eur. J. 14 (2008) 4675
38. Mitsunobu O. Synthesis (1981) 1
39. Mouse thrombosis model: Pulmonary thromboembolism was induced by a method as described by DiMinno and Silver (1983). The compounds to be tested (30 μM/kg), standard drugs or the vehicle were administered by oral route 60 min prior to the thrombotic challenge. Ten mice were used for evaluating the effect of test compound, while a group of five mice was used to evaluate the effect of aspirin or vehicle. A mixture of collagen and adrenaline was injected into the tail vein to induce hind limb paralysis or death. Results have been reported as% protection, which represent protection against hind limb paralysis or death. The test compounds exhibiting protection equivalent to Aspirin (30 mg/kg) were considered as active molecules. (Dimnno, G.; Silver, M. J. J. Pharmacol. Exp. Therap. 1983, 225, 57-60).
40. Bleeding time: Bleeding time in mice was evaluated by the method of Dejana et al. (1979) to assess the increase in bleeding time in comparison to aspirin at its optimal antithrombotic dose. The tail 2 mm from tip of mice was incised and the blood oozed was soaked on a filter paper, which was monitored at an interval of 10-15 s till the bleeding stopped. The time elapsed from the tip incision to the stoppage of bleeding was recorded as the bleeding time. The tested compounds (30 μM/kg), aspirin (30 mg/kg) or vehicle was given orally 60 min prior to the tail incision in a group of 5 mice each. (Dejna, E.; Collioni, A.; Quntana, A. Thromb. Res. 1979, 15, 191).
41. Batra S., Roy A.K., Patra A., Bhaduri A.P., Surin W.R., Raghavan S.A.V., Sharma P., Kapoor K., and Dikshit M. Bioorg. Med. Chem. 12 (2004) 2059
42. Patra A., Batra S., Bhaduri A.P., Khanna A., Chander R., and Dikshit M. Bioorg. Med. Chem. 11 (2003) 2269
43. Batra S., Srinivasan T., Rastogi S.K., Kundu B., Patra A., Bhaduri A.P., and Dixit M. Bioorg. Med. Chem. Lett. 12 (2002) 1905
44. Saxena A.K., Pandey S.K., Seth P., Singh M.P., Dikshit M., and Carpy A. Bioorg. Med. Chem. 9 (2001) 2025